Virginia Cancer Specialists Announces 21 Physicians Named to Washingtonian “Top Doctors” Hall of Fame

June 17, 2026

Virginia Cancer Specialists Selected as National ASTRO Training Center to Expand Access to Radiopharmaceutical Therapy

Alexander I Spira MD, Alex Spira, Gregory S. Sibley, Harold Agbahiwe

June 4, 2026

Breakthrough Targeted Therapy Shows Promise for KRAS‑Mutated Pancreatic Cancer, with Virginia Cancer Specialists and NEXT Oncology Playing Key Role

May 12, 2026

New Treatment Breakthrough: Amivantamab Plus Lazertinib for Advanced Lung Cancer - Timothy A. McCarthy, MD

Lung Cancer Team, Alex Spira, Clinical Trials and Research, Lung Cancer, Timothy A. McCarthy

July 22, 2024

Investigational Inhibitor of Active RAS Shows Clinical Promise - Alexander I. Spira, MD, PhD, FACP

Clinical Trials Search, Alex Spira, Clinical Trials and Research

October 16, 2023

Landmark Non-Small Cell Lung Cancer Study - Clinically Meaningful Improvement and Progression Free Survival, Alexander I. Spira, MD, PhD, FACP 

September 28, 2023

A Rare Breakthrough in the Treatment of Colorectal Cancer Patients Harboring a KRAS mutation.

Alex Spira, Colon & Rectal Cancer, Clinical Trials and Research

March 7, 2023

NEXT-Virginia Opens Phase I Clinical Research Clinic for Oncology Patients in collaboration with Virginia Cancer Specialists

NEXT Oncology, The Research Institute, Alex Spira, Clinical Trials and Research, Press Releases

January 10, 2023

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C - Co-Author Alexandar Spira, MD, PhD, FACP

Alex Spira, Colon & Rectal Cancer

January 9, 2023

Advancements in Lung Cancer Treatment Provide Hope for Virginia Cancer Specialists Patients - Alexander I. Spira, MD, PhD, FACP

Lung Cancer Team, Alex Spira, Lung Cancer

November 10, 2022

Shine A Light on Lung Cancer 2022

October 13, 2022

Ground breaking research leading to breakthroughs in cancer treatments - Timothy A. McCarthy, MD

July 11, 2022

Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial

NEXT Oncology, The Research Institute, Alex Spira, Non-Small Cell Lung Cancer

June 27, 2022

Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting - Alexander I. Spira, MD, PhD, FACP

Fairfax Office, Alex Spira

June 3, 2022

RESECTABLE NSCLC AND THE IMPORTANCE OF GUIDELINE-RECOMMENDED MOLECULAR TESTING

February 22, 2022

Journal of Clinical Oncology - ASCO Pub - Abstract - Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spira, MD, PhD, FACP

Alex Spira, GI Cancer

January 20, 2022

Virginia Cancer Specialists Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

The Research Institute, Alex Spira, Clinical Trials and Research, Mitul Gandhi

October 11, 2021

Next Oncology Expands Phase I Program with Virginia Cancer Specialists Partnership

NEXT Oncology, Alex Spira, Clinical Trials and Research

October 6, 2021

A monumental step forward in the treatment of non-small cell lung cancer patients harboring a KRAS mutation, Dr. Christina Brzezniak

Lung Cancer Team, Christina Brzezniak, Alex Spira, Lung Cancer, Non-Small Cell Lung Cancer

June 16, 2021

Alexander I Spira, MD, PhD, FACP - Sotorasib for Lung Cancers with KRAS p.G12C Mutation, The New England Journal of Medicine

Alex Spira, Lung Cancer

June 4, 2021

Exploring Why Testing in Lung Cancer is Important to Treatment Decisions - Alex Spira, MD, PhD, FACP

Alex Spira, Lung Cancer

February 23, 2021

Virginia Cancer Specialists Joins MYLUNG Consortium, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

The Research Institute, Alex Spira, Clinical Trials and Research, Lung Cancer

February 4, 2021

Interview with Dr. Alex Spira - Medpage Today Lung Cancer and Covid19

Alex Spira, Lung Cancer

June 16, 2020

Alex Spira, MD PhD FACP VCS Co-Author Virginia Cancer Specialists - JAMA Network - Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas Clinical Trial

Alex Spira, Clinical Trials and Research, The Sarcoma Center, Sarcoma

April 9, 2020

Alexander Spira, MD, PhD, FACP, on the recent approval of atezolizumab in SCLC

Alex Spira, Lung Cancer

April 2, 2019

Virginia Cancer Specialists (VCS) Now Offering a Newly FDA-Approved Targeted Therapy for Acute Leukemia

Alex Spira, Clinical Trials and Research, Leukemia, Hematology and Blood Cancers, Dipti Patel-Donnelly

February 4, 2019

Advancements in Science and Cancer Care Research Announced at the US Oncology Research 17th Annual Science Forum - Dr. Alex Spira

The Research Institute, Alex Spira

October 8, 2018

Co Author Alex Spira, MD - Lung Cancer Study Treatment Option for ALK Positive Lung Cancer Patients

Alex Spira, Lung Cancer

September 25, 2018

Alex Spira, M.D., PhD, F.A.C.P. receives award for his work in Lung Cancer

Alex Spira, Lung Cancer

September 20, 2018

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

The Research Institute, Alex Spira, Amy J. Irwin MD

May 22, 2018

Dr. Alex Spira quoted in announcement from Mirati Theraputics: Progress Of Lead Programs And Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials

Alex Spira, Immunotherapy, Clinical Trials and Research

April 26, 2018

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

The Research Institute, Alex Spira, Clinical Trials and Research, Leukemia

March 6, 2018

Alex Spira, MD Co-Author of collaborative study on Immunotherapy guidelines to guide clinicians and patients

Alex Spira, Immunotherapy

February 15, 2018

Virginia Cancer Specialists enrolls fist patient in Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (AML)

Clinical Trials Search, The Research Institute, Alex Spira, Clinical Trials and Research, Leukemia

February 7, 2018

Northern Virginia 2018 Thoracic Oncology Symposium, CME Program - March 10th 2018

Alex Spira, CME Event, Timothy A. McCarthy

January 30, 2018